Letter Sequence Withholding Request Acceptance |
|---|
EPID:L-2018-LLA-0194, License Amendment Request and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel (Approved, Closed) |
|
MONTHYEARML18187A4172018-07-0606 July 2018
License Amendment Request and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel
Project stage: Request
ML18271A0392018-10-0202 October 2018
Non Proprietary - Supplemental Information Needed for Acceptance of Requested License Amendments and Exemptions Implementation of Framatome High Thermal Performance Fuel (Epids L-2018-LLA-0194 and L-2018-LLE-0010)
Project stage: Acceptance Review
ML18296A4662018-10-18018 October 2018
Supplemental Information Regarding License Amendment Request and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel
Project stage: Supplement
ML18312A3322018-11-13013 November 2018
Acceptance Review for License Amendment and Exemption Requests Regarding the Implementation of Framatome High Thermal Performance Fuel
Project stage: Acceptance Review
ML18333A2272018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated October 18, 2018, Executed by Mr. Bruce Rash of APS
Project stage: Withholding Request Acceptance
ML18333A1632018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated July 6, 2018, Executed by Mr. Bruce Rash of APS
Project stage: Withholding Request Acceptance
ML18333A0712018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated May 16, 2018, Executed by Mr. Philip A. Opsal, from Framatome, Inc
Project stage: Withholding Request Acceptance
ML18333A0592018-12-0404 December 2018
Request for Withholding Information from Public Disclosure, Affidavit Dated March 9, 2018, Executed by Mr. Philip A. Opsal, from Framatome, Inc
Project stage: Withholding Request Acceptance
ML19011A1082019-01-15015 January 2019
First Regulatory Audit Plan for January 22-23, 2019, in Support of Framatome
Project stage: Other
ML19060A2982019-03-0101 March 2019
Transmittal of Audit Presentation Slides Regarding License Amendment Request and Exemption Request to Support the Implementation of Framatome CE16HTP Fuel
Project stage: Request
ML19065A2542019-03-18018 March 2019
Request for Withholding Information from Public Disclosure, Affidavit Dated February 28, 2019, Executed by Mr. Bruce Rash, Arizona Public Service Company
Project stage: Withholding Request Acceptance
ML19065A2212019-03-18018 March 2019
Request for Withholding Information from Public Disclosure, Affidavit Dated February 22, 2019, Executed by Mr Philip A. Opsal, Framatome, Inc
Project stage: Withholding Request Acceptance
ML19098A1872019-04-0505 April 2019
NRR E-mail Capture - Palo Verde 1, 2, and 3 - Official RAIs from Irab for Framatome Htp Fuel LAR and Exemption (EPIDs L-2018-LLA-0194 and L-2018-LLE-0010)
Project stage: RAI
ML19137A1182019-05-17017 May 2019
Response to NRC Staff Request for Additional Information from Reactor Assessment and Human Performance Branch Regarding License Amendment and Exemption Requests Related to the Implementation of Framatome High Thermal
Project stage: Request
ML19154A4692019-06-0404 June 2019
Second Regulatory Audit Plan for June 17-20, 2019, in Support of Framatome High Thermal Performance Fuel License Amendment Request and Exemption
Project stage: Other
ML19218A2932019-08-13013 August 2019
Regulatory Audit Report for the January 22-23, 2019, Audit for the License Amendment and Exemption Requests Assoc. W/Framatome High Thermal Performance Fuel (EPID L-2018-LLA-0194; EPID L-2018-LLE-0010)
Project stage: Other
ML19234A3202019-08-29029 August 2019
Redacted - Request for Additional Information for Amendment and Exemption Request to Support the Implementation of Framatome High Thermal Performance Fuel (EPID L-2018-LLA-0194; EPID L-2018-LLE-0010)
Project stage: RAI
ML19235A2562019-09-0909 September 2019
Regulatory Audit Summary for the June 17-20, 2019, Audit for the License Amendment and Exemption Requests Associated with Framatome High Thermal Performance Fuel
Project stage: Other
ML19277J4572019-10-0404 October 2019
Response to NRC Request for Additional Information Regarding License Amendment and Exemption Requests Related to the Implementation of Framatome CE16HTP Fuel
Project stage: Response to RAI
ML19282C4432019-10-21021 October 2019
Request for Withholding Information from Public Disclosure - 5/29/19 Affidavit Executed by Nathan Hottle, Framatome, Inc. ANP-3785P, Revision 0
Project stage: Withholding Request Acceptance
ML19282A6702019-10-24024 October 2019
Request for Withholding Information from Public Disclosure, 10/4/19 Affidavit Executed by Bruce Rash, Arizona Public Service Company RAI Responses
Project stage: RAI
ML19282B6432019-10-24024 October 2019
Request for Withholding Information from Public Disclosure, 9/25/19 Affidavit Executed by Gayle Elliott, Framatome, Inc. ANP-3639P, Revision 1Q1P, Revision 0, and ANP-3640Q1P, Revision 0
Project stage: Withholding Request Acceptance
ML19301A9052019-10-30030 October 2019
Third Regulatory Audit Plan for November 7-8, 2019, in Support of Framatome High Thermal Performance Fuel License Amendment Request and Exemption
Project stage: Other
ML19331A3612019-11-26026 November 2019
Supplemental Response to NRC Request for Additional Information Regarding License Amendment and Exemption Requests Related to the Implementation of Framatome CE16HTP Fuel
Project stage: Supplement
ML19337A4992019-12-18018 December 2019
Request for Withholding Information from Public Disclosure Related to 11/14/19 Affidavit Executed by K. Hosack, Westinghouse
Project stage: Withholding Request Acceptance
ML19337A0322019-12-18018 December 2019
Request for Withholding Information from Public Disclosure, 11/25/19 Affidavit Executed by Mr. Phil Opsal, Framatome, Inc. Framatome ANP-3640Q2P, Revision 0
Project stage: Withholding Request Acceptance
ML19337A0372019-12-18018 December 2019
Request for Withholding Information from Public Disclosure, 10/25/19 Affidavit Executed by Bruce Rash, Arizona Public Service Company RAI Responses Dated 11/26/19
Project stage: RAI
ML19353C0382019-12-19019 December 2019
Supplemental Information Related to Framatome CE16HTP Fuel LAR Requests for Additional Information Bhtp RAl-05 and Bhtp RAl-06
Project stage: Supplement
ML20031D6012020-02-13013 February 2020
Audit Summary for the Nov. 7-8, 2019, Audit for the License Amendment and Exemption Requests Associated with Framatome High Thermal Performance Fuel (EPID L-2018-LLA-0194 & EPID L-2018-LLE-0010)
Project stage: Other
ML20050C9742020-02-19019 February 2020
NRR E-mail Capture - Palo Verde 1,2, and 3 - Framatome Htp Fuel LAR and Exemption Third Audit Summary (EPIDs L-2018-LLA-0194 and L-2018-LLE-0010)
Project stage: Approval
ML20031C9472020-03-0404 March 2020
Nonproprietary, Issuance of Amendment Nos. 212, 212, and 212 to Revise Technical Specifications to Support the Implementation of Framatome High Thermal Performance Fuel
Project stage: Approval
2019-12-18
[Table View] |
Text
December 18, 2019 Mr. Robert S. Bement Executive Vice President Nuclear/
Chief Nuclear Officer Mail Station 7602 Arizona Public Service Company P.O. Box 52034 Phoenix, AZ 85072-2034
SUBJECT:
PALO VERDE NUCLEAR GENERATING STATION, UNITS 1, 2, AND 3 -
REQUEST FOR WITHHOLDING INFORMATION FROM PUBLIC DISCLOSURE (EPID L-2018-LLA-0194)
Dear Mr. Bement:
By letter dated November 26, 2019 (Agencywide Documents Access and Management System (ADAMS) Accession No. ML19331A361), Arizona Public Service Company (the licensee) submitted an affidavit dated November 25, 2019, to the U.S. Nuclear Regulatory Commission (NRC), executed by Mr. Phil Opsal, Manager, Product Licensing, for Framatome Inc.
(Framatome), requesting that the information contained in the following document (Attachment 11 of the letter dated November 26, 2019) be withheld from public disclosure pursuant to Title 10 of the Code of Federal Regulations (10 CFR), Part 2, Section 2.390:
Framatome ANP-3640Q2P, Revision 0, Palo Verde Units 1, 2 and 3 Small Break LOCA [Loss-of-Coolant Accident] Summary Report NRC RAI [Request for Additional Information] Responses, November 2019.
A non-proprietary copy of this document, contained in Attachment 9 of the enclosure to your letter dated November 26, 2019, has been placed in the NRCs Public Document Room and added to the NRC Library in ADAMS at the above-referenced Accession No. ML19331A361.
The affidavit dated November 25, 2019, stated that the submitted information should be considered exempt from mandatory public disclosure for the following reasons:
(d)
The information reveals certain distinguishing aspects of a process, methodology, or component, the exclusive use of which provides a.
competitive advantage for Framatome in product optimization or marketability.
(e)
The information is vital to a competitive advantage held by Framatome, would be helpful to competitors to Framatome, and would likely cause substantial harm to the competitive position of Framatome.
We have reviewed your application and the material in accordance with the requirements of 10 CFR 2.390 and, on the basis of the statements in the affidavit, have determined that the
submitted information sought to be withheld contains proprietary commercial information and should be withheld from public disclosure.
Therefore, the submitted information marked as proprietary will be withheld from public disclosure pursuant to 10 CFR 2.390(b)(5) and Section 103(b) of the Atomic Energy Act of 1954, as amended.
Withholding from public inspection shall not affect the right, if any, of persons properly and directly concerned to inspect the documents. If the need arises, we may send copies of this information to our consultants working in this area. We will, of course, ensure that the consultants have signed the appropriate agreements for handling proprietary information.
If the basis for withholding this information from public inspection should change in the future such that the information could then be made available for public inspection, you should promptly notify the NRC. You also should understand that the NRC may have cause to review this determination in the future, for example, if the scope of a Freedom of Information Act request includes your information. In all review situations, if the NRC makes a determination adverse to the above, you will be notified in advance of any public disclosure.
If you have any questions regarding this matter, please contact me at 301-415-1564 or via e-mail at Siva.Lingam@nrc.gov.
Sincerely,
/RA/
Siva P. Lingam, Project Manager Plant Licensing Branch IV Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket Nos. STN 50-528, STN 50-529, and STN 50-530 cc: Mr. Phil Opsal Manager, Product Licensing Framatome Inc.
3315 Old Forest Road Lynchburg, VA 24501 Listserv
ML19337A032 OFFICE NRR/DORL/LPL4/PM NRR/DORL/LPL4/LA NRR/DSS/SFNB/BC NAME SLingam PBlechman RLukes DATE 12/3/19 12/3/19 12/4/19 OFFICE NRR/DSS/SNSB/BC(A)
NRR/DORL/LPL4/BC NRR/DORL/LPL4/PM NAME JBorromeo JDixon-Herrity SLingam DATE 12/17/19 12/18/19 12/18/19
